Breaking News Instant updates and real-time market news.

AGN

Allergan

$163.79

34.14 (26.33%)

, ABBV

AbbVie

$66.51

-11.905 (-15.18%)

12:50
06/25/19
06/25
12:50
06/25/19
12:50

Allergan upgraded to Equal Weight from Underweight at Barclays

Barclays analyst Balaji Prasad upgraded Allergan (AGN) to Equal Weight from Underweight to reflect the company's agreement to be acquired by AbbVie (ABBV).

AGN

Allergan

$163.79

34.14 (26.33%)

ABBV

AbbVie

$66.51

-11.905 (-15.18%)

  • 25

    Jun

  • 16

    Sep

AGN Allergan
$163.79

34.14 (26.33%)

06/25/19
MZHO
06/25/19
NO CHANGE
Target $171
MZHO
Buy
Allergan price target lowered to $171 from $194 at Mizuho
Mizuho analyst Irina Koffler lowered her Botox Cosmetic and CoolSculpt estimates after conducting a survey of 20 dermatologists and plastic surgeons, who gave the impression that that the Botox franchise will be pressured by Evolus (EOLS) and other new entrants. Koffler cut her price target on Allergan shares to $171 from $194 based on the lowered estimates, but maintains a Buy rating on the stock, stating that it is "widely expected" that the company will make a strategic announcement that begins the preliminary work of separating the company in the next 1-2 months.
ABBV AbbVie
$66.51

-11.905 (-15.18%)

06/25/19
LEER
06/25/19
NO CHANGE
LEER
Outperform
Bid of $188 for Allergan 'too low,' others may pursue as well, says SVB Leerink
SVB Leerink analyst Marc Goodman is not surprise that one of the large pharma companies has made a bid on Allergan (AGN) given the multi-year stock weakness. However, he believes a $188 price is "too low," as he "can't believe that Allergan is not being taken out at least at $200," which "begs the question" whether this was a process or is AbbVie (ABBV) "opportunistically pursuing a wounded stock." If it is the latter, Goodman believes this bid could initiate others to pursue Allergan as well. He has an Outperform rating on Allegan's shares.
06/25/19
WELS
06/25/19
NO CHANGE
WELS
Outperform
Deals with premiums like Allergan's 'rarely killed,' says Wells Fargo
After Abbvie (ABBV) announced an agreement to acquire Allergan (AGN) for $120 per share of cash and a remaining $68 in AbbVie shares, Wells Fargo analyst David Maris said he views the deal as a good alternative for Allergan versus the current share price, but he is not convinced its a better long term alternative given the eventual biosimilar threat to Abbvie's blockbuster drug Humira. With that said, Maris tells investors that "deals at such premiums are rarely killed because of a bad strategic fit or longer -term value outlook in the absence of other bidders." Though he would not completely rule out an activist investor disrupting the deal, he thinks it is unlikely given there has been a strategic review of the company for some time. Maris, who said he thinks the deal could go through, keeps an Outperform rating on Allergan shares.
06/25/19
PIPR
06/25/19
NO CHANGE
PIPR
Neutral
Piper says 'willing to listen' to AbbVie reasoning for Allergan acquisition
Ahead of the call to discuss AbbVie's (ABBV) planned $63B acquisition of Allergan (AGN), Piper Jaffray analyst Christopher Raymond said his first reaction to the deal could be summed up with the phrase "two turkeys don't make an eagle," but he is "willing to listen" despite his skepticism about the transaction. Though he cannot say he is "excited at the prospect of AbbVie entering the field of medical aesthetics," EPS accretion of 10% in year one and over 20% at peak, and the potential for meaningful deleveraging and cost cutting, has his attention, Raymond said. He keeps a Neutral rating on AbbVie based on his initial reaction to the deal announcement.
06/13/19
PIPR
06/13/19
NO CHANGE
Target $90
PIPR
Neutral
AbbVie rheumatology franchise feedback incrementally positive, says Piper
Piper Jaffray analyst Christopher Raymond says he sees "incrementally positive feedback" for AbbVie's rheumatology franchise. A new Rheumatologist survey indicates "strong expectations" for the upadacitinib launch, which has an FDA action date of August 19, Raymond tells investors in a research note. The analyst is "compelled" to raise his upadacitinib numbers ahead of approval. However, he keeps a Neutral rating on AbbVie sahres with a $90 price target saying his broader Humira competitive concerns remain in place.

TODAY'S FREE FLY STORIES

FXI

iShares China Large-Cap ETF

$42.28

0.09 (0.21%)

10:20
07/17/19
07/17
10:20
07/17/19
10:20
Options
Short-term put buyer in China ETF bought delta neutral »

Short-term put buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
07/17/19
07/17
10:17
07/17/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAGS

PagSeguro Digital

$45.50

0.78 (1.74%)

, OPRA

Opera

$11.00

0.41 (3.87%)

10:16
07/17/19
07/17
10:16
07/17/19
10:16
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

PAGS

PagSeguro Digital

$45.50

0.78 (1.74%)

OPRA

Opera

$11.00

0.41 (3.87%)

WORK

Slack Technologies

$34.19

-0.24 (-0.70%)

JLL

Jones Lang LaSalle

$140.23

-0.06 (-0.04%)

ALSN

Allison Transmission

$47.46

-0.1 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 06

    Aug

  • 06

    Aug

HSY

Hershey

$144.07

3.64 (2.59%)

, COP

ConocoPhillips

$60.31

0.57 (0.95%)

10:16
07/17/19
07/17
10:16
07/17/19
10:16
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

HSY

Hershey

$144.07

3.64 (2.59%)

COP

ConocoPhillips

$60.31

0.57 (0.95%)

CTRP

Ctrip

$38.35

1.48 (4.01%)

KBH

KB Home

$26.58

-0.16 (-0.60%)

SLGN

Silgan Holdings

$30.47

0.09 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 30

    Jul

MFGP

Micro Focus

$21.23

0.57 (2.76%)

, WFC

Wells Fargo

$45.45

0.15 (0.33%)

10:16
07/17/19
07/17
10:16
07/17/19
10:16
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

MFGP

Micro Focus

$21.23

0.57 (2.76%)

WFC

Wells Fargo

$45.45

0.15 (0.33%)

ARLP

Alliance Resource Partners

$16.87

-0.38 (-2.20%)

WUBA

58.com

$57.07

-0.68 (-1.18%)

RL

Ralph Lauren

$111.09

-4.07 (-3.53%)

LEVI

Levi Strauss

$18.76

-1.05 (-5.30%)

PVH

PVH Corp.

$89.89

-2.61 (-2.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 30

    Jul

  • 01

    Aug

  • 19

    Sep

  • 19

    Sep

  • 12

    Oct

  • 15

    Oct

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
07/17/19
07/17
10:16
07/17/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOYU

DouYu

$0.00

(0.00%)

10:15
07/17/19
07/17
10:15
07/17/19
10:15
Syndicate
Breaking Syndicate news story on DouYu »

DouYu indicated to open…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

LEVI

Levi Strauss

$18.74

-1.07 (-5.40%)

10:15
07/17/19
07/17
10:15
07/17/19
10:15
Options
Levi Strauss put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
07/17/19
07/17
10:15
07/17/19
10:15
General news
Fed funds futures have a light bid »

Fed funds futures have a…

10:15
07/17/19
07/17
10:15
07/17/19
10:15
General news
Breaking General news story  »

Week of 7/12 EIA…

DOYU

DouYu

$0.00

(0.00%)

10:13
07/17/19
07/17
10:13
07/17/19
10:13
Syndicate
Breaking Syndicate news story on DouYu »

DouYu indicated to open…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

DOYU

DouYu

$0.00

(0.00%)

10:09
07/17/19
07/17
10:09
07/17/19
10:09
Syndicate
Breaking Syndicate news story on DouYu »

DouYu indicated to open…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

DOYU

DouYu

$0.00

(0.00%)

10:05
07/17/19
07/17
10:05
07/17/19
10:05
Syndicate
DouYu indicated to open at $12.00, IPO priced at $11.50 »

DouYu (DOYU) priced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

TELL

Tellurian

$6.94

-0.74 (-9.64%)

10:05
07/17/19
07/17
10:05
07/17/19
10:05
Options
Tellurian call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

CTK

CooTek

$9.17

(0.00%)

10:00
07/17/19
07/17
10:00
07/17/19
10:00
Hot Stocks
CooTek falls -7.2% »

CooTek is down -7.2%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWB

Great Western

$32.31

-2.69 (-7.69%)

10:00
07/17/19
07/17
10:00
07/17/19
10:00
Hot Stocks
Great Western falls -7.5% »

Great Western is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 10

    Sep

  • 11

    Sep

NUS

Nu Skin

$37.55

-7.95 (-17.47%)

10:00
07/17/19
07/17
10:00
07/17/19
10:00
Hot Stocks
Nu Skin falls -17.4% »

Nu Skin is down -17.4%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

NM

Navios Maritime

$5.64

0.3 (5.62%)

10:00
07/17/19
07/17
10:00
07/17/19
10:00
Hot Stocks
Navios Maritime rises 5.8% »

Navios Maritime is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSM

Fortuna Silver Mines

$3.36

0.185 (5.83%)

10:00
07/17/19
07/17
10:00
07/17/19
10:00
Hot Stocks
Fortuna Silver Mines rises 5.8% »

Fortuna Silver Mines is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORN

Orion Group

$4.12

0.36 (9.57%)

10:00
07/17/19
07/17
10:00
07/17/19
10:00
Hot Stocks
Orion Group rises 9.3% »

Orion Group is up 9.3%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

TSLA

Tesla

$257.74

5.36 (2.12%)

09:57
07/17/19
07/17
09:57
07/17/19
09:57
Periodicals
Officials worry over Tesla's plan to unleash robo-cars, Washington Post says »

Tesla is racing to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 06

    Aug

ABT

Abbott

$86.34

3.23 (3.89%)

09:56
07/17/19
07/17
09:56
07/17/19
09:56
Hot Stocks
Abbott says 'running as fast as we can in Europe' »

Says: Has paid down a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

KKR

KKR

$26.05

0.01 (0.04%)

09:55
07/17/19
07/17
09:55
07/17/19
09:55
Options
KKR put volume heavy and directionally bearish »

Bearish flow noted in KKR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

NCI

Navigant Consulting

$23.68

(0.00%)

09:55
07/17/19
07/17
09:55
07/17/19
09:55
Conference/Events
Senate Environment & Public Works Committee to hold a hearing »

The Senate Committee on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 19

    Sep

09:55
07/17/19
07/17
09:55
07/17/19
09:55
Conference/Events
House Transportation & Intrastructure Committee to hold a hearing »

The Subcommittee on…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.